Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Loewenstein – page 3

34 clinical trials in Loewenstein, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Loewenstein at a glance
34
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

34 trials in Loewenstein

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Domvanalimab
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:F. Hoffmann-La Roche AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:F. Hoffmann-La Roche AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Irinotecan
  • Sponsor:Pharma Mar S.A.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Adagrasib
  • Sponsor:Mirati Therapeutics Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Dostarlimab
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:F. Hoffmann-La Roche AG

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Loewenstein

What the registry says about research in the country

01 Lung Cancer Research

Extensive clinical trials focusing on non-small cell lung cancer (NSCLC) and various treatment approaches, including immunotherapy combinations and targeted therapies.

  • Advanced NSCLC Treatment
  • Immunotherapy Studies
  • Targeted Molecular Therapies

Innovative treatments evaluating novel drug combinations and their effectiveness in different stages of lung cancer.

02 Pulmonary Conditions

Research investigating treatments for various forms of pulmonary fibrosis and respiratory conditions, with a focus on innovative inhaled therapies.

  • Progressive Pulmonary Fibrosis
  • Idiopathic Pulmonary Fibrosis
  • Fibrotic Lung Disease

Studies examining long-term safety and efficacy of respiratory treatments using advanced delivery methods.

03 Precision Medicine

Targeted research on specific genetic mutations including KRAS G12C and other molecular markers in lung cancer patients.

  • Genetic Mutation Studies
  • Biomarker Research
  • Personalized Treatment Approaches

Development of tailored therapeutic strategies based on individual patient genetic profiles.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.